[Conduct disorder, unsocialized and socialized].
Nakane
Akira
A
Division of Childhood and Adolescence, Tokyo Institute of Psychiatry.
D014150:Antipsychotic Agents / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000150:complications; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D019955:Conduct Disorder / Q000175:diagnosis / Q000209:etiology / Q000523:psychology / Q000628:therapy; D039721:Diagnostic and Statistical Manual of Mental Disorders; D006801:Humans; D008774:Methylphenidate / Q000627:therapeutic use; D011613:Psychotherapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D012931:Social Environment
D014150:Antipsychotic Agents; D000697:Central Nervous System Stimulants; D008774:Methylphenidate; D017367:Selective Serotonin Reuptake Inhibitors